DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Appeal No. 6984 of 2026 filed by Muhammad Aadil

SEBI 1 hr ago·13 Aug 2026, 4:33 am

Company SEBI

The Securities and Exchange Board of India (SEBI) has received an appeal filed by investor Muhammad Aadil. This legal action seeks to challenge a specific regulatory order passed by SEBI.

This development is significant because it highlights ongoing investor disputes with the market regulator. The outcome of this appeal could influence how similar cases are handled in the future, potentially setting a precedent for investor rights.

Investors should monitor the status of this case closely. A decision in favor of the appellant might signal a shift in regulatory enforcement, while a dismissal would reinforce the current framework. It is a matter to watch for broader market implications.